Skip to content
XPR
content.
Press releases
Video
Podcasts
Op-eds
Lists
Guest posts
Author:
AlzeCure Pharma
Communique from the Annual General Meeting of AlzeCure Pharma on 29 June 2026
June 29, 2026
Positive Results From The Phase Ib Clinical Study of NeuroRestore ACD856, Under Development for Alzheimer’s
June 16, 2026
AlzeCure Pharma Enters Into A Collaboration And Out-Licensing Agreement With Lilly For Alzheimer’s Project
June 9, 2026
←
Previous Page
1
2